Trial Profile
An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics and Safety After Administration of HCP1105 Alone and Co-administration of HGP0918 and HGP0816 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs HCP 1105 (Primary) ; HGP 0816 (Primary) ; HGP 0918 (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 25 Oct 2016 New trial record